AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Capital expenditures

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2021-0+85.59%
Mar 31, 2019-0-72.18%
Mar 31, 2018-0-88.16%
Mar 31, 2017-3+1673.16%
Mar 31, 2016-0-60.08%
Mar 31, 2015-0-80.66%
Mar 31, 2010-2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)